158 related articles for article (PubMed ID: 37139238)
21. Single-cell transcriptome revealed dysregulated RNA-binding protein expression patterns and functions in human ankylosing spondylitis.
Ren Z; Li C; Wang J; Sui J; Ma Y
Front Med (Lausanne); 2024; 11():1369341. PubMed ID: 38770048
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas.
Yu S; Zhang J; Ding Y; Kang X; Pu X
Front Genet; 2022; 13():937623. PubMed ID: 36147491
[TBL] [Abstract][Full Text] [Related]
23. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
25. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
26. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Identification of Immune-Related Alternative Splicing and Splicing Regulators Involved in Abdominal Aortic Aneurysm.
Wu S; Liu S; Chen N; Zhang C; Zhang H; Guo X
Front Genet; 2022; 13():816035. PubMed ID: 35251127
[TBL] [Abstract][Full Text] [Related]
28. Modulator-Dependent RBPs Changes Alternative Splicing Outcomes in Kidney Cancer.
Wang Y; Chen SX; Rao X; Liu Y
Front Genet; 2020; 11():265. PubMed ID: 32273884
[TBL] [Abstract][Full Text] [Related]
29. m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma.
Bi Y; Meng D; Wan M; Xu N; Xu Y; Yuan K; Liu P; Fang H; Hu H; Lan S
Comput Intell Neurosci; 2022; 2022():9315283. PubMed ID: 35978902
[TBL] [Abstract][Full Text] [Related]
30. ISG15 is a potential therapeutic target for osteosarcoma: a comprehensive analysis based on bioinformatics and in vitro experiments.
Liao Y; Zhang X; Tang J; Hu F; Li D; Song H; Chen J; Guo J; Li R; Lin Y; Xie L
Am J Transl Res; 2023; 15(2):817-833. PubMed ID: 36915723
[TBL] [Abstract][Full Text] [Related]
31. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
32. Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration.
Chen Z; Li L; Li Z; Wang X; Han M; Gao Z; Wang M; Hu G; Xie X; Du H; Xie Z; Zhang H
Cancer Cell Int; 2022 Feb; 22(1):78. PubMed ID: 35151325
[TBL] [Abstract][Full Text] [Related]
33. The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases.
He Q; Li Z; Lei X; Zou Q; Yu H; Ding Y; Xu G; Zhu W
Cancer Cell Int; 2021 Jun; 21(1):325. PubMed ID: 34193169
[TBL] [Abstract][Full Text] [Related]
34. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
35. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
36. rMAPS: RNA map analysis and plotting server for alternative exon regulation.
Park JW; Jung S; Rouchka EC; Tseng YT; Xing Y
Nucleic Acids Res; 2016 Jul; 44(W1):W333-8. PubMed ID: 27174931
[TBL] [Abstract][Full Text] [Related]
37. Identification of therapeutic targets for osteosarcoma by integrating single-cell RNA sequencing and network pharmacology.
Wang Y; Qin D; Gao Y; Zhang Y; Liu Y; Huang L
Front Pharmacol; 2022; 13():1098800. PubMed ID: 36686663
[No Abstract] [Full Text] [Related]
38. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
[No Abstract] [Full Text] [Related]
39. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
PeerJ; 2022; 10():e14084. PubMed ID: 36213507
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
